Filtered By:
Management: Economics
Vaccination: Cervical Cancer Vaccine

This page shows you your search results in order of date.

Order by Relevance | Date

Total 5 results found since Jan 2013.

Impact of including boys in the national school-based human papillomavirus vaccination programme in Singapore: A modelling-based cost-effectiveness analysis
Vaccine. 2023 Feb 14:S0264-410X(23)00160-3. doi: 10.1016/j.vaccine.2023.02.025. Online ahead of print.ABSTRACTGlobally, gender-neutral Human Papillomavirus (HPV) vaccination programmes are gaining traction. Although cervical cancer remains the most prevalent, other HPV-related cancers are increasingly recognised as important, especially among men who have sex with men. We assessed if including adolescent boys in Singapore's school-based HPV vaccination programme is cost-effective from the healthcare perspective. We adapted a World Health Organization-supported model, Papillomavirus Rapid Interface for Modelling and Economi...
Source: Vaccine - February 16, 2023 Category: Allergy & Immunology Authors: Muhammad Taufeeq Wahab Rayner Kay Jin Tan Alex R Cook Kiesha Prem Source Type: research

Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review
ConclusionsHPV vaccination and screening interventions may be cost effective in LMICs and potentially reduce the lifetime risk, economic burden, and associated mortality. However, it is important to consider the factors that influence the cost effectiveness of cervical cancer prevention interventions for better outcomes to be realised.
Source: Applied Health Economics and Health Policy - May 28, 2020 Category: Health Management Source Type: research